Skip to content
Canada's Drug & Health Product Regulatory Experts
  • Home
    • Français
  • About
    • About SPharm
    • Why choose SPharm
    • SPharm Regulatory Milestones
    • Leadership Team
  • Services
    • Services overview
    • Health Product Regulatory Services
    • eCTD
    • Product Development
    • Pharmacovigilance
    • Compliance and Quality
    • Regulatory Training & Consulting
  • Resource Library
    • eGuides, Whitepapers, Infographics, Articles
    • The Ultimate Glossary of Drug Regulatory Terms for Canada
  • News/Posts
  • Contact
  • Home
    • Français
  • About
    • About SPharm
    • Why choose SPharm
    • SPharm Regulatory Milestones
    • Leadership Team
  • Services
    • Services overview
    • Health Product Regulatory Services
    • eCTD
    • Product Development
    • Pharmacovigilance
    • Compliance and Quality
    • Regulatory Training & Consulting
  • Resource Library
    • eGuides, Whitepapers, Infographics, Articles
    • The Ultimate Glossary of Drug Regulatory Terms for Canada
  • News/Posts
  • Contact
  • Request Proposal
  • FR
  • Request Proposal
  • FR
Canada's Drug & Health Product Regulatory Experts
  • Home
    • Français
  • About
    • About SPharm
    • Why choose SPharm
    • SPharm Regulatory Milestones
    • Leadership Team
  • Services
    • Services overview
    • Health Product Regulatory Services
    • eCTD
    • Product Development
    • Pharmacovigilance
    • Compliance and Quality
    • Regulatory Training & Consulting
  • Resource Library
    • eGuides, Whitepapers, Infographics, Articles
    • The Ultimate Glossary of Drug Regulatory Terms for Canada
  • News/Posts
  • Contact
  • Home
    • Français
  • About
    • About SPharm
    • Why choose SPharm
    • SPharm Regulatory Milestones
    • Leadership Team
  • Services
    • Services overview
    • Health Product Regulatory Services
    • eCTD
    • Product Development
    • Pharmacovigilance
    • Compliance and Quality
    • Regulatory Training & Consulting
  • Resource Library
    • eGuides, Whitepapers, Infographics, Articles
    • The Ultimate Glossary of Drug Regulatory Terms for Canada
  • News/Posts
  • Contact
  • Request Proposal
  • FR
  • Request Proposal
  • FR
 
16 November 2016
Health Canada announces the issuance of a new Guidance GUI-0064: How Health Canada inspects medical device establishments. These guidelines will help anyone with a medical device establishment licence, understand and prepare for an inspection as well as to ensure that they are carried out in a consistent manner. http://www.hc-sc.gc.ca/dhp-mps/alt_formats/pdf/compli-conform/info-prod/md-im/md_insp_prog-prog_insp_mm-eng.pdf
SPharm Canada

With a quarter of a century of consistent and successful results, SPharm has become one of the leading Drug Regulatory Advisory firms in Canada. Drug companies from around the world count on SPharm to help them navigate the drug (and other health products) review & approval process in Canada.

Avec un quart de siècle de résultats et de succès constants , SPharm est devenue une entreprise de services de référence au Canada en stratégie de développement de médicaments et affaires réglementaires. Des compagnies pharmaceutiques à travers le monde comptent sur SPharm pour faciliter le processus d’homologation de leurs médicaments (et autres produits de santé) au Canada.

canadian drug approval process clinical trial approval canada drug approval consultant canada drug approval consultants canada drug approval process in canada drug regulatory consultant canada drug regulatory process canada Guidance GUI-0064 health canada drug approval
TwitterLinkedInEmail
Canada's Drug & Health Product Regulatory Experts

© 2022 SPharm. All Rights Reserved.

Request Proposal
Linkedin Envelope
Services
  • Drug Regulatory Services in Canada
  • Electronic Common Technical Document – eCTD
  • Product Development
  • Pharmacovigilance
  • Compliance and quality
  • Regulatory Training & Consulting
Key Guides & Articles
  • AN eGUIDE – The Drug Review and Approval Process in Canada
  • AN INFOGRAPHIC – Drug Review & Approval Process in Canada
  • Canadian Drug Regulatory Glossary
  • Overcoming Obstacles in the Drug Approval Process in Canada
SPharm
  • Home
  • About Us
  • Services
  • Resource Library
  • News and Posts
  • Contact
  • Français